Drug Profile
One page per molecule: approvals, exclusivity, makers, supply, demand, pricing, safety and listings.
Open Drug Profile -- in the sidebar under Drug Intelligence.
Drug Profile is the single most-used page in Qope. It takes one drug name and assembles everything the public registries know about it into one document.
Searching
Type a brand name or an ingredient name into the search box.
- Lookup uses exact FDA Orange Book and Purple Book names. Type the full brand (
Lipitor,Humira) or the full ingredient (atorvastatin calcium). - Brand names resolve to the underlying molecule, so searching
Lipitorand searchingatorvastatin calciumreach the same profile. - If nothing matches, Qope offers up to five suggested names rather than an empty page.
Add &vs=<other drug> (or use the compare control) to place two profiles side by side.
The landing dashboard
With no search term, the page shows a landing dashboard: signal carousels of drugs currently worth looking at, drawn from live shortage, cliff and pricing data. It is a starting point, not a saved view.
Header
The hero header carries the primary name, the ingredient, the market-state summary, and the action bar:
- Watch -- adds the molecule to your Radar drug watchlist.
- Add to list -- saves it to a lead list.
- Export -- downloads the profile brief.
- Compare -- opens the two-drug comparison.
Tabs
Tabs appear only when the underlying data exists for that molecule. A profile with no Medicare Part D presence has no Demand tab.
Overview
The product record: application numbers, approval dates, dosage forms, routes, applicants, marketing status. Below it, the marketed-products card and the contestability meter -- how many generic makers are actively marketing, how many hold approvals that are all discontinued, whether an AB-rated substitutable generic exists, and whether a Reference Listed Drug is on file.
The Verdict
A plain-language read of the drug's market position, scored for three audiences:
| Persona | Question it answers |
|---|---|
| Generic entrant | Is this worth filing on? |
| Procurement | Is supply reliable and priced sensibly? |
| Investor | Is the revenue defensible? |
Each verdict shows a rating, a headline, a recommended action, and the full list of factors that moved the score up or down, with the points each contributed. The scoring is a ranking device, not a forecast -- read the factors, not just the number.